Explore more publications!

Technology Journal Nepal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Journal Nepal.

Press releases published on February 9, 2026

CORRECTION - Procedureflow
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit
DBV Technologies participeà la conférence Emerging Outlook: Biotech Summit organisée par Guggenheim Securities
YXT.com Announces Changes in Board of Directors and Management
Microchip Technology to Present at the Wolfe Research Auto, Auto Tech and Semiconductor Conference
Agomab Announces Closing of Initial Public Offering
Magnite to Participate in the Susquehanna 15th Annual Technology Conference
Mobile Infrastructure Announces Timing of Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
CEA Industries Appoints Accounting and Compliance Expert Glenn W. Tyranski to Its Board of Directors
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences
Paul O’Donnell Serving as Executive Chairman, Supporting Procedureflow’s Continued Growth
Society Pass Incorporated (Nasdaq: SOPA) and NusaTrip Incorporated (Nasdaq: NUTR) Strengthened its Presence in the Tourism Market with Collaboration with Huizhi International Tourism Development Co Ltd
Synfini Introduces Integrated Microscale Purification, Delivering Assay-Ready Compounds in Hours Instead of Days
Kaleris Unveils Smarter Cold Chain Orchestration at Manifest 2026
Geekvape Neutra: Design for a Low-Carbon Future
AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet® in the treatment of canine mast cell tumors
AB Science annonce que la Food and Drug Administration (FDA) américaine a accordé le statut de Minor Use in Major Species (MUMS) au Masivet® dans le traitement des tumeurs mastocytaires chez le chien
Dataminr Solutions Now Available in AWS Marketplace Through Carahsoft

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions